← Alle mensen

JM

Josiane Mourão Dias

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Gevorderd NSCLC: A Gerandomiseerde, Double-Blind, E...
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-11
Totale overleving with Amivantamab-Lazertinib in EGFR-Mutated Gevorderd NSCLC.
The New England journal of medicine · 30 oktober 2025
Amivantamab plus lazertinib als eerstelijns bij EGFR-gemuteerd NSCLC: MARIPOSA fase III definitief
The New England journal of medicine · 24 oktober 2024
Bintrafusp alfa versus pembrolizumab bij PD-L1-hoog NSCLC: INTR@PID Lung 037 fase III
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023-12
Amivantamab plus chemotherapie bij EGFR exon 20 inserties NSCLC: PAPILLON fase III
The New England journal of medicine · 30 november 2023